Crossmark

Adverse effects and discontinuation rates for darifenacin in overactive urinary bladder: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00210-025-04806-4

Published Online: 2026-01-09

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Veer, Vineesha https://orcid.org/0000-0002-0933-1952
Smith, Felicity https://orcid.org/0009-0003-8767-0268
Scott, Anna Mae https://orcid.org/0000-0002-0109-9001
Moro, Christian https://orcid.org/0000-0003-2190-8301
Funding

Funding for this research was provided by:

Bond University Limited
License Information

Text and Data Mining valid from 2026-01-09

Version of Record valid from 2026-01-09
More Information

Article History

Received: 26 May 2025

Accepted: 9 November 2025

First Online: 9 January 2026

Declarations

:

: Ethics is not required for this analysis of already-published public research.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below